Following trends in prostate cancer deaths in the U.S., however, is the most powerful argument in favor of PSA screening. Since the introduction of this test over 20 years ago, we have witnessed a ...

The JAMA study should not be interpreted as a reason to forego PSA testing altogether. On the contrary, PSA should continue to be an important part of prostate cancer screening. However, patients ...

Studies such as these have generated excitement that new blood and urine tests will ultimately solve the PSA problem. But molecular biomarkers such as exosomes and miRNAs aren’t the only game in ...

A blood sample drawn for a PSA test. Maybe the biggest problem with the PSA test is the rush to treat every cancer found, some doctors say. (Mark Boster / Los Angeles Times) By Rosie Mestel, Los ...

Issues include troubles in China for both PSA and Fiat Chrysler, excess capacity in Fiat's European factories, PSA's over-reliance on Europe for profits, and poor results at Maserati and Alfa Romeo.